SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001014108-23-000151
Filing Date
2023-12-13
Accepted
2023-12-13 17:20:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ftg-sc13g_12132023.htm SC 13G 57723
  Complete submission text file 0001014108-23-000151.txt   58976
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 617-229-6499
Finch Therapeutics Group, Inc. (Subject) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92403 | Film No.: 231484953
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 158 FILMORE STREET DENVER CO 80206
Business Address
Ugwumba Chidozie (Filed by) CIK: 0001835544 (see all company filings)

Type: SC 13G